asthma

By Jeff Lagasse September 1, 2017
Melbourne, Australia-based Adherium, a digital health company that focuses in improving medication adherence and patient outcomes, has just received FDA clearance for a new inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, dubbed the SmartTouch for Symbicort.   The SmartTouch is a device that grafts onto a patient’s inhaler to monitor and encourage medication adherence as...
By Jeff Lagasse August 24, 2017
Propeller Health, a company that trains its digital eye on respiratory medicine, first partnered with GSK in 2015. Now, that collaboration is being expanded -- enabling both companies to prepare for, and undertake, commercial activities using the Propeller clip-on sensor and software platform for use with GSK’s ELLIPTA Inhaler.   Ongoing research and development efforts will continue, with...
By Jonah Comstock June 21, 2017
Madison, Wisconsin-based Propeller Health is now a decade old. The digital health company, which makes connected inhalers and patient- and provider-facing data analytics tools for respiratory diseases asthma and COPD, can hardly be considered a startup anymore. Nowadays the company has numerous published efficacy studies and business relationships with most major pharma companies in the...
By Heather Mack April 18, 2017
Dublin, Ohio-based Monitored Therapeutics, Inc. (MTI) has received FDA 510(k) clearance for its connected spirometer, GoSpiro. The device, which calculates diagnostic-quality air capacity measurement, was designed specifically for use in a non-clinical setting. As calculations are performed inside the device, GoSpiro can work with any smartphone, tablet or computer without the need for separate...
By Heather Mack March 15, 2017
New York City-based Cohero Health, which develops connected health tools and technologies for chronic respiratory diseases, has closed on $10.5 million in Series A funding. This builds on the company’s earlier $9 million Series A round from late 2016, and the extra funding comes from new strategic investors Samsung Next and Omron Healthcare. With seed funding, this brings Cohero's total funding...
By Heather Mack March 13, 2017
A new study demonstrates that conducting some studies entirely via smartphones is feasible, fruitful and scalable: it stands up to scientific rigor, allows for large-scale participant enrollment,and captures unique environmental data not available through traditional methods, as researchers at the Icahn School of Medicine at Mount Sinai have learned. In a new article published today in the...
By Heather Mack February 8, 2017
Digital respiratory health management company Propeller Health is collaborating with Novartis to develop a custom add-on sensor for the Swiss pharmaceutical company’s Breezhaler inhaler, which is used for Novartis’s portfolio of COPD treatments. The partnership will be focused in Europe. The add-on sensor will be developed to work with the capsule-based dry powder inhaler by passively recording...
By Jonah Comstock November 17, 2016
Correction: A previous version of this article misstated the adherence figure.  Adherium’s Smartinhaler has been shown to increase medication adherence by 43 percent and reduce hospitalization by a factor of five, according to a new study conducted at Sheffield Children’s Hospital in the UK and published in the journal Thorax. The randomized control trial included 77 children with asthma. “This...
By Heather Mack November 7, 2016
Madison, Wisconsin-based Propeller Health, maker of several smart inhaler sensors and companion apps, has received FDA 510(k) clearance for its latest offering – a sensor that works with GlaxoSmithKline’s Ellipta inhaler. This marks the company’s eighth FDA clearance, and was born out of a partnership the company struck up with GSK last December. Given Propeller's growing familiarity with the...
By Jonah Comstock August 22, 2016
Asthma UK, a British nonprofit dedicated to fighting asthma, has released a report highlighting the role connected health has to play in treating asthma and reducing the number of preventable deaths from the disease.  "At Asthma UK we are determined to stop asthma attacks." Asthma UK CEO Kay Boycott writes in the introduction to the report. "Outcomes have plateaued in recent years and this must...